The global transplant diagnostics market is growing rapidly, mainly due to the many innovations that have transpired in the field of diagnostics. Additionally, these innovations are enhancing the quality of life of people by delivering miraculous results. Transplant diagnostics play a crucial role in reducing the rate of organ rejection. Rise in chronic diseases has elevated the demand for assays capable of diagnosing histocompatibility prior to transplantation.
According to Market Research Future (MRFR), the transplant diagnostics market is anticipated to touch USD 2,074.65 MN by 2023. In its recently published research report, MRFR also asserts that the market would register a CAGR over 7.80% throughout the assessment period (2018-2023). Rise in funding for research and development activities by public-private organizations is a key factor bolstering the growth of the market.
Free Sample copy is here @ https://www.marketresearchfuture.com/sample_request/1324
Market Leading Players
Illumina, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F. Hoffmann La Roche Ltd., bioMérieux SA, and QIAGEN NV, among others.
Segmentation:
By component, the global transplant diagnostics market is segmented into instruments, reagents and consumables, and software and services. Reagents and consumables are likely to be the major driving force for the global transplant diagnostics market over the forecast period, as they are used in high volumes and frequently replenished.
By screening type, the market is segmented into pre-transplant and post-transplant screening.
On the basis of the organ being transplanted, the global transplant diagnostics market is segmented into heart, lungs, liver, pancreas, kidney, and others.
On the basis of application, the global transplant diagnostics market is segmented into diagnostics, research, and others.
By end use, the global transplant diagnostics market is segmented into hospitals and transplant centers, commercial service providers, research laboratories and academic institutes, and others. Hospitals and transplant centers are likely to be the major revenue generator for the global transplant diagnostics market over the forecast period.
Industry Updates:
In December 2018, Novacyt launched two new diagnostic test kits for post-transplant monitoring. These include the genesig Real-Time PCR BK virus (BKV) Kit (CE) and genesig Real-Time PCR Epstein-Barr Virus (EBV) Kit (CE).
Also in December 2018, CareDx Inc. released new data confirming the utility of its AlloSure test to diagnose allograft health in repeat kidney transplant patients.
Access the full report here @ https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324
Key Questions Answered in This Report:
- What will the market size and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
